DRUG/PRODUCT ALERT
Actos, ActoplusMet, Competact and Duetact
The United States Food and Drug Administration (FDA) has issued a warning about the diabetes drug pioglitazone, sold as Actos, ActoplusMet, Competact, and Duetact.
Actos is an oral diabetes medicine that recent studies have shown leads to serious injuries such as an increased risk of bladder cancer.
WHAT SHOULD YOU DO?
If you or a loved one has taken Actos, and have suffered bladder cancer, contact your doctor's office or hospital about treatment. In order to determine whether you have a right to compensation for your injuries, please contact Galfand Berger, LLP at 1-800-222-8792 for a free, no-obligation consultation.
